- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 217/02 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
Patent holdings for IPC class C07D 217/02
Total number of patents in this class: 387
10-year publication summary
|
30
|
25
|
31
|
20
|
30
|
27
|
19
|
20
|
18
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alcon, Inc. | 5163 |
27 |
| Aerie Pharmaceuticals, Inc. | 62 |
12 |
| Pfizer Inc. | 3373 |
7 |
| D. Western Therapeutics Institute, Inc. | 22 |
7 |
| Bausch + Lomb Ireland Limited | 675 |
7 |
| Centre National de La Recherche Scientifique | 10052 |
6 |
| Universite de Montpellier | 960 |
6 |
| Janssen Pharmaceutica N.V. | 3625 |
5 |
| Abivax | 111 |
5 |
| Institut Curie | 556 |
5 |
| SpecGx LLC | 195 |
5 |
| The Regents of the University of California | 19479 |
4 |
| Merck Patent GmbH | 5849 |
4 |
| Epizyme, Inc. | 386 |
4 |
| Icahn School of Medicine at Mount Sinai | 895 |
4 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 160 |
4 |
| The University of Queensland | 656 |
4 |
| Fosun Orinove Pharmatech, Inc. | 16 |
4 |
| Bristol-myers Squibb Company | 4886 |
3 |
| Allergan, Inc. | 2445 |
3 |
| Other owners | 261 |